Hydroxyzine vs Ondansetron

Ondansetron is considered one of the most effective antiemetics available. It was originally developed for chemotherapy-induced nausea and vomiting (CINV), where it revolutionized supportive care. It is also highly effective for postoperative nausea and vomiting (PONV), radiation-induced nausea, and gastroenteritis-related vomiting. Clinical trials have consistently shown ondansetron to be superior to older antiemetics for these indications.

Hydroxyzine has moderate antiemetic efficacy and is typically used when nausea has an anxiety component, for motion sickness, or as part of preoperative sedation protocols where both anxiolysis and antiemetic effects are desired. It is less effective than ondansetron for severe nausea such as CINV. However, its combined antiemetic, anxiolytic, and sedating properties make it useful when these multiple effects are clinically desirable.

For pure antiemetic efficacy, ondansetron is generally superior. Hydroxyzine may be preferred when sedation and anxiety relief are additional treatment goals.

Ondansetron is well tolerated with relatively few side effects. The most common include headache, constipation, and fatigue. A notable safety concern is QT prolongation, particularly with IV administration or in patients with pre-existing cardiac conditions. The FDA has restricted the maximum single IV dose to 16mg due to this risk. Ondansetron does not cause sedation, making it suitable for outpatient use when alertness is important.

Hydroxyzine's primary side effect is sedation, which can be significant. Other effects include dry mouth, dizziness, blurred vision, and constipation due to its anticholinergic properties. It can impair driving and cognitive function. Hydroxyzine also carries a risk of QT prolongation at higher doses. It should be used cautiously in elderly patients due to anticholinergic effects and fall risk.

Ondansetron's non-sedating profile is a significant advantage for patients who need to remain functional while managing nausea.

Generic ondansetron is affordable, typically costing $10-25 for a course of treatment. Orally disintegrating tablets (ODT) may cost slightly more. It is widely available and well covered by insurance. Over-the-counter availability has been discussed but ondansetron currently requires a prescription.

Generic hydroxyzine is similarly inexpensive at $5-20 for a typical course. Both medications are available on most pharmacy $4 generic lists.

For patients with insurance, cost difference is minimal between the two. Both represent good value for their respective indications.

Ondansetron is available in multiple convenient formulations: oral tablets, orally disintegrating tablets (which dissolve on the tongue — ideal for patients who are actively vomiting), oral solution, and injectable forms. The ODT formulation is particularly practical since it does not require water to take. Dosing is typically every 8 hours as needed.

Hydroxyzine is available as tablets, capsules, oral solution, and injectable forms. It is typically dosed every 6-8 hours. The sedation it causes limits its convenience for daytime use when patients need to be alert.

Ondansetron is the preferred choice for chemotherapy-induced nausea, postoperative nausea, radiation-induced nausea, and acute gastroenteritis in both adults and children. Its strong efficacy and non-sedating profile make it the go-to antiemetic in most clinical settings. It is particularly valuable when patients need to remain alert and functional.

Hydroxyzine may be preferred when nausea is accompanied by significant anxiety, when sedation is desirable (pre-operative settings, insomnia with nausea), or for motion sickness. It is sometimes used in emergency departments for patients with nausea and anxiety who would benefit from both effects simultaneously.

For most patients seeking nausea relief, ondansetron provides superior antiemetic efficacy with fewer side effects. Consult your healthcare provider to determine which medication is most appropriate for your specific situation.